Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.

about

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.

Item

http://www.wikidata.org/entity/Q42653035

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Posttranslational modification ...... rkers for Parkinson's disease.

@en

Posttranslational modification ...... rkers for Parkinson's disease.

@nl

type

Item

label

Posttranslational modification ...... rkers for Parkinson's disease.

@en

Posttranslational modification ...... rkers for Parkinson's disease.

@nl

prefLabel

Posttranslational modification ...... rkers for Parkinson's disease.

@en

Posttranslational modification ...... rkers for Parkinson's disease.

@nl

P1476

Posttranslational modification ...... arkers for Parkinson's disease

@en

P2093

Elisa Miranda

http://www.w3.org/2001/XMLSchema#string

Joaquim J Ferreira

http://www.w3.org/2001/XMLSchema#string

Leonor Correia-Guedes

http://www.w3.org/2001/XMLSchema#string

Miguel Coelho

http://www.w3.org/2001/XMLSchema#string

Mário Miguel Rosa

http://www.w3.org/2001/XMLSchema#string

Rafaela Cássio

http://www.w3.org/2001/XMLSchema#string

Tiago Soares

http://www.w3.org/2001/XMLSchema#string

P2860

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease

alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells

Protein folding and misfolding

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

The sour side of neurodegenerative disorders: the effects of protein glycation.

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

P2888

s41598-017-14175-5

P304

13713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-14175-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hugo Vicente Miranda

Ana Chegão

Marcos António Gomes

Tiago Fleming Outeiro

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057912

http://www.w3.org/2001/XMLSchema#string

P921

Synuclein

P932

5651848

http://www.w3.org/2001/XMLSchema#string